JP2009046391A - Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action - Google Patents
Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action Download PDFInfo
- Publication number
- JP2009046391A JP2009046391A JP2005244955A JP2005244955A JP2009046391A JP 2009046391 A JP2009046391 A JP 2009046391A JP 2005244955 A JP2005244955 A JP 2005244955A JP 2005244955 A JP2005244955 A JP 2005244955A JP 2009046391 A JP2009046391 A JP 2009046391A
- Authority
- JP
- Japan
- Prior art keywords
- cachexia
- cancer
- improving
- preparation
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010006895 Cachexia Diseases 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 39
- 235000013305 food Nutrition 0.000 title claims abstract description 22
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 230000009471 action Effects 0.000 title description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 22
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 20
- 235000020232 peanut Nutrition 0.000 claims description 20
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 19
- 235000018262 Arachis monticola Nutrition 0.000 claims description 19
- 230000006872 improvement Effects 0.000 claims description 13
- 230000001225 therapeutic effect Effects 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 241001553178 Arachis glabrata Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 26
- 239000000284 extract Substances 0.000 abstract description 23
- 201000010099 disease Diseases 0.000 abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 17
- 201000011510 cancer Diseases 0.000 abstract description 15
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 9
- 208000030172 endocrine system disease Diseases 0.000 abstract description 9
- 201000008827 tuberculosis Diseases 0.000 abstract description 9
- 244000057114 Sapium sebiferum Species 0.000 abstract description 5
- 235000005128 Sapium sebiferum Nutrition 0.000 abstract description 4
- 244000105624 Arachis hypogaea Species 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 235000013399 edible fruits Nutrition 0.000 description 13
- 244000025254 Cannabis sativa Species 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 9
- 241001330002 Bambuseae Species 0.000 description 9
- 235000008708 Morus alba Nutrition 0.000 description 9
- 240000000249 Morus alba Species 0.000 description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 8
- 235000017491 Bambusa tulda Nutrition 0.000 description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 description 8
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 8
- 239000011425 bamboo Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 208000017701 Endocrine disease Diseases 0.000 description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 6
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 6
- 102000014150 Interferons Human genes 0.000 description 6
- 108010050904 Interferons Proteins 0.000 description 6
- 240000000513 Santalum album Species 0.000 description 6
- 235000008632 Santalum album Nutrition 0.000 description 6
- 244000273928 Zingiber officinale Species 0.000 description 6
- 235000006886 Zingiber officinale Nutrition 0.000 description 6
- 235000008397 ginger Nutrition 0.000 description 6
- 229940010454 licorice Drugs 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 235000007516 Chrysanthemum Nutrition 0.000 description 5
- 102000004889 Interleukin-6 Human genes 0.000 description 5
- 108090001005 Interleukin-6 Proteins 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 229940079322 interferon Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 206010025482 malaise Diseases 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 4
- 235000013162 Cocos nucifera Nutrition 0.000 description 4
- 244000060011 Cocos nucifera Species 0.000 description 4
- 240000008067 Cucumis sativus Species 0.000 description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 4
- 244000236655 Diospyros kaki Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 241000234435 Lilium Species 0.000 description 4
- 206010025323 Lymphomas Diseases 0.000 description 4
- 241000282320 Panthera leo Species 0.000 description 4
- 241000994241 Sapium Species 0.000 description 4
- 206010039491 Sarcoma Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000004596 appetite loss Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000003038 endothelium Anatomy 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 208000014987 limb edema Diseases 0.000 description 4
- 208000019017 loss of appetite Diseases 0.000 description 4
- 235000021266 loss of appetite Nutrition 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000222336 Ganoderma Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000170916 Paeonia officinalis Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 241000508269 Psidium Species 0.000 description 3
- 235000005733 Raphanus sativus var niger Nutrition 0.000 description 3
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 3
- 235000018735 Sambucus canadensis Nutrition 0.000 description 3
- 244000151637 Sambucus canadensis Species 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000007123 blue elder Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000007124 elderberry Nutrition 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 235000008995 european elder Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 235000007756 Akebia quinata Nutrition 0.000 description 2
- 240000008027 Akebia quinata Species 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 2
- 235000010518 Canavalia gladiata Nutrition 0.000 description 2
- 241000252229 Carassius auratus Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000272201 Columbiformes Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 240000001723 Entada phaseoloides Species 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000013719 Houttuynia cordata Nutrition 0.000 description 2
- 240000000691 Houttuynia cordata Species 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 2
- 206010034811 Pharyngeal cancer Diseases 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 241000220259 Raphanus Species 0.000 description 2
- 244000155437 Raphanus sativus var. niger Species 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000002495 Uterine Neoplasms Diseases 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 201000005787 hematologic cancer Diseases 0.000 description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940127084 other anti-cancer agent Drugs 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 206010046766 uterine cancer Diseases 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GMVPRGQOIOIIMI-DODZYUBVSA-N 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DODZYUBVSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 235000016413 Actinidia polygama Nutrition 0.000 description 1
- 240000006274 Actinidia polygama Species 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- QCZXQEYEVLCQHL-UHFFFAOYSA-N Amanin Natural products O=C1NC(CC(O)=O)C(=O)N2CC(O)CC2C(=O)NC(C(C)C(O)CO)C(=O)NC(C2)C(=O)NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC1CS(=O)C1=C2C2=CC=CC=C2N1 QCZXQEYEVLCQHL-UHFFFAOYSA-N 0.000 description 1
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 1
- 241000499945 Amaryllis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 201000003076 Angiosarcoma Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000499950 Arthropodium cirratum Species 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000526704 Berberis thunbergii Species 0.000 description 1
- 235000018585 Berchemia racemosa Nutrition 0.000 description 1
- 240000001881 Berchemia racemosa Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 206010004593 Bile duct cancer Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000722713 Carcharodon carcharias Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 244000025596 Cassia laevigata Species 0.000 description 1
- 235000006693 Cassia laevigata Nutrition 0.000 description 1
- 240000005674 Ceanothus americanus Species 0.000 description 1
- 235000014224 Ceanothus americanus Nutrition 0.000 description 1
- 235000001904 Ceanothus herbaceus Nutrition 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000034870 Chrysoteuchia culmella Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 244000309456 Decussocarpus nagi Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000008597 Diospyros kaki Nutrition 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000001976 Endocrine Gland Neoplasms Diseases 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 102000012004 Ghrelin Human genes 0.000 description 1
- 101800001586 Ghrelin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 235000004036 Glehnia littoralis Nutrition 0.000 description 1
- 244000146486 Glehnia littoralis Species 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000208253 Gymnema sylvestre Species 0.000 description 1
- 241000511338 Haliaeetus leucocephalus Species 0.000 description 1
- 235000015030 Hedychium spicatum Nutrition 0.000 description 1
- 240000003237 Hedychium spicatum Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000001258 Hemangiosarcoma Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 241000519695 Ilex integra Species 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000102542 Kara Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010023825 Laryngeal cancer Diseases 0.000 description 1
- 235000010671 Lathyrus sativus Nutrition 0.000 description 1
- 240000005783 Lathyrus sativus Species 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 241000604893 Lindera umbellata Species 0.000 description 1
- 241000319062 Lycoris radiata Species 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- 235000014196 Magnolia kobus Nutrition 0.000 description 1
- 240000005378 Magnolia kobus Species 0.000 description 1
- 208000032271 Malignant tumor of penis Diseases 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- HBPQPBSTHOHSFP-UHFFFAOYSA-N OC(=O)C([Pt])=O Chemical compound OC(=O)C([Pt])=O HBPQPBSTHOHSFP-UHFFFAOYSA-N 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010061534 Oesophageal squamous cell carcinoma Diseases 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- 206010031096 Oropharyngeal cancer Diseases 0.000 description 1
- 206010057444 Oropharyngeal neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001441732 Ostraciidae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000282373 Panthera pardus Species 0.000 description 1
- 241001147389 Panthera uncia Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010061336 Pelvic neoplasm Diseases 0.000 description 1
- 208000002471 Penile Neoplasms Diseases 0.000 description 1
- 206010034299 Penile cancer Diseases 0.000 description 1
- 235000000857 Pentadesma butyracea Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000081757 Phalaris arundinacea Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 235000010913 Picrasma quassioides Nutrition 0.000 description 1
- 240000004659 Picrasma quassioides Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241001315609 Pittosporum crassifolium Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 241000283011 Rangifer Species 0.000 description 1
- 241000282941 Rangifer tarandus Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 description 1
- 241001104043 Syringa Species 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 206010062129 Tongue neoplasm Diseases 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000023915 Ureteral Neoplasms Diseases 0.000 description 1
- 206010046392 Ureteric cancer Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 206010047741 Vulval cancer Diseases 0.000 description 1
- 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 241001222097 Xenocypris argentea Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 208000004064 acoustic neuroma Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 201000006966 adult T-cell leukemia Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- QCZXQEYEVLCQHL-MIBTZWEZSA-N amanin Chemical compound O=C1N[C@@H](CC(O)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H]1CS(=O)C1=C2C2=CC=CC=C2N1 QCZXQEYEVLCQHL-MIBTZWEZSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004597 appetite gain Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 208000026900 bile duct neoplasm Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000008609 bushi Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 190000008236 carboplatin Chemical compound 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 201000011523 endocrine gland cancer Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 208000007276 esophageal squamous cell carcinoma Diseases 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000005962 mycosis fungoides Diseases 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 208000027831 neuroepithelial neoplasm Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 201000006958 oropharynx cancer Diseases 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 208000021284 ovarian germ cell tumor Diseases 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000009996 pancreatic endocrine effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 235000008954 quail grass Nutrition 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 208000015347 renal cell adenocarcinoma Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 208000008732 thymoma Diseases 0.000 description 1
- 201000006134 tongue cancer Diseases 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 208000037965 uterine sarcoma Diseases 0.000 description 1
- 206010046885 vaginal cancer Diseases 0.000 description 1
- 208000013139 vaginal neoplasm Diseases 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000005102 vulva cancer Diseases 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
- JLQFVGYYVXALAG-CFEVTAHFSA-N yasmin 28 Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 JLQFVGYYVXALAG-CFEVTAHFSA-N 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Medical Informatics (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明は、がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの疾患における悪液質改善治療製剤および悪液質改善作用を有する食品製剤に関する。 The present invention relates to a cachexia-improving therapeutic preparation and a food preparation having a cachexia-improving action in diseases such as cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis and the like.
がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの疾患が悪化した時には、全身的衰弱、倦怠感、食欲不振、るいそう(極度のやせ)、顔色蒼白、行動不能等の症状が起きる。顔瞼または下腿の浮腫、皮膚の乾燥弛緩、眼窩・両頬の凹み、との特徴のある顔貌(悪液質顔貌)を呈する。このような状態は、「悪液質(cachexia)」をいう。悪液質は、蛋白質をはじめとする種々の代謝異常やトキソホルモンにより生じた病態と考えられている。悪液質は、患者生存の質(quality of life;QOL)の極端な低下を引き起こす。 When diseases such as cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis worsen, symptoms such as generalized weakness, malaise, loss of appetite, irritability (extreme skinnyness), complexion, paleness, inability to act Get up. It has a characteristic facial appearance (cachexia), such as facial edema or lower leg edema, dry and loose skin, and dents in the eyes and cheeks. Such a condition refers to “cachexia”. Cachexia is considered to be a pathological condition caused by various metabolic abnormalities including proteins and toxohormones. Cachexia causes an extreme decrease in patient quality of life (QOL).
生化学的には、電解質異常(例えば、高カルシウム血症)と、腫瘍壊死因子−α(tumor necrosis factor;TNF−α)、インターロイキン−6(interleukin、IL−6)、インターフェロン(interferon;IFN)、トキソホルモン(toxohormone)などの生理活性物質含有量の上昇がみられる。 Biochemically, electrolyte abnormalities (eg, hypercalcemia), tumor necrosis factor-α (TNF-α), interleukin-6 (interleukin, IL-6), interferon (IFN); ), An increase in the content of physiologically active substances such as toxohormones.
悪液質状態(特に倦怠感、食欲不振、るいそう)の改善は、患者に日常的行動能力を与え、患者およびその家族の精神的苦痛を軽減し、生存の質を向上させ、臨床的にも、社会的にも極めて大きな意味を持っている。 Improving cachexia (especially malaise, loss of appetite, and anxiety) empowers patients to perform daily behavior, reduces mental distress for patients and their families, improves quality of survival, and clinically However, it has a great social significance.
これまで、悪液質に対し、対症的な治療方法しかなく、有効な治療方法はない。我が国で対症的に使用されている薬物は、第一選択としてプリンペラン、第二選択としてヒスロンH、第三選択としてステロイドである(非特許文献1、非特許文献2、非特許文献3)。しかし、これらの薬はいずれも強い副作用がある。悪液質状態までに病状が進行した患者は、もはやこれらの薬の副作用を耐え切る体力はない。 Until now, there is only a symptomatic treatment method for cachexia, and there is no effective treatment method. Drugs that are used symptomatically in Japan are purinperan as the first choice, hystron H as the second choice, and steroids as the third choice (Non-patent Document 1, Non-patent
それで、近年、天然薬用植物における抗悪液質作用の研究が行われるようになった。これまで、悪液質改善に効果のある天然薬用植物は、黄連(非特許文献4)、薬用人参(非特許文献5)、十全大補湯(薬用人参、ブクリョウ、ビャクジュツ、カンゾウ、トウキ、シャクヤク、センキュウ、ジオウ、ニッキ、ブシとの十種類の生薬の混合物、非特許文献6)等が挙げられる。 In recent years, therefore, research has been conducted on anti-cachexia effects in natural medicinal plants. So far, natural medicinal plants that are effective in improving cachexia are Huang Ren (Non-patent Document 4), Ginseng (Non-patent Document 5), Juzen Daihoto (Medical Ginseng, Bukkyou, Sandalwood, Licorice, Toki) , Peony, nematode, diau, nikki, and a mixture of 10 kinds of herbal medicines, non-patent document 6) and the like.
しかし、これらの植物は、生化学的指標(TNF−α、IFN、IL−6等)における改善がデータ上にみられたものの、臨床からみれば、効き目があまりにも薄く、満足した効果が得られない。 However, these plants showed improvements in biochemical indicators (TNF-α, IFN, IL-6, etc.) on the data, but the clinical effect was too thin, and a satisfactory effect was obtained. I can't.
そこで、本発明は、抗がん作用の認められた植物ナンキンハゼ(特許文献1)の悪液質改善における作用を検討した。 Therefore, the present invention examined the action of the plant Nankin goby (Patent Document 1), which has been recognized as having an anticancer action, in improving cachexia.
本発明の目的は、悪液質に対し顕著な臨床効果があり、尚且つ副作用がない悪液質改善治療製剤およびその食品製剤を提供することにある。 An object of the present invention is to provide a cachexia-improving therapeutic preparation and a food preparation thereof that have a remarkable clinical effect on cachexia and that have no side effects.
さらに、本発明の目的は、がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの患者が悪液質状態にならないよう、有効な予防製剤並びに食品製剤を提供することにある。 Furthermore, an object of the present invention is to provide an effective prophylactic preparation and food preparation so that patients with cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis and the like do not become cachexia.
本発明は、ナンキンハゼの優れた悪液質改善作用を有することを見出した。 It has been found that the present invention has an excellent cachexia-improving action of peanut.
本発明の悪液質改善治療製剤は、ナンキンハゼまたその抽出物を有効成分として含む。 The cachexia-improving therapeutic preparation of the present invention contains nankin goby or an extract thereof as an active ingredient.
本発明の悪液質予防並びに改善食品製剤は、ナンキンハゼまたその抽出物を有効成分として含む。 The cachexia prevention and improvement food preparation of the present invention contains peanut or a extract thereof as an active ingredient.
本発明において、「がん(cancer)」とは、上皮細胞を起源とする癌腫(carcinoma)と、骨や筋肉などの非上皮性細胞に由来する肉腫(sarcoma)、分泌組織を起源とする腺癌(adenomas)、リンパ組織を起源とするリンパ腫(lymphoma)、メラニン産生細胞(melanocyte)から生じるメラノーマ(melanoma)、生殖細胞組織の中に発生する奇形腫(teratoma)、造血細胞の腫瘍化による造血器腫瘍、神経上皮由来の腫瘍である脳腫瘍をいう。 In the present invention, “cancer” means a carcinoma derived from epithelial cells, a sarcoma derived from non-epithelial cells such as bones and muscles, and a gland originating from secretory tissue. Cancer (adenomas), lymphoma originating from lymphoid tissue (lymphoma), melanoma arising from melanocyte, melanoma arising in germ cell tissue, hematopoiesis due to tumorigenicity of hematopoietic cells It refers to brain tumors that are organ tumors or neuroepithelial tumors.
また、本発明において、「ナンキンハゼの抽出物」とは、ナンキンハゼから溶媒によって抽出された抽出液、あるいはこの抽出液の乾燥物をいうものとする。 Further, in the present invention, “a extract of peanut” refers to an extract extracted from a peanut with a solvent or a dried product of this extract.
本発明の悪液質改善治療剤によれば、ナンキンハゼおよび/またはその抽出物を有効成分として含むことにより、重篤な副作用がなく、がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの患者の悪液質状態を改善することができる。よって、本発明の悪液質改善治療製剤は、例えば、悪液質改善製剤、および/またはその治療製剤、および/またはその食品製剤、および/またはその機能食品製剤として有用である。本発明の製剤によれば末期患者の悪液質を改善し、QOLを向上させることができる。 According to the cachexia improving therapeutic agent of the present invention, there are no serious side effects by containing nankin goby and / or its extract as an active ingredient, cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis. The patient's cachexia condition can be improved. Therefore, the cachexia improving therapeutic preparation of the present invention is useful, for example, as a cachexia improving preparation and / or a therapeutic preparation thereof, and / or a food preparation thereof, and / or a functional food preparation thereof. According to the preparation of the present invention, cachexia of end-stage patients can be improved and QOL can be improved.
本発明の悪液質改善治療製剤、および/または悪液質予防製剤並びにその食品製剤(以下、これを「組成物」ともいう)は、ナンキンハゼおよび/またはその抽出物を有効成分として含む。 The cachexia-improving therapeutic preparation and / or cachexia-preventing preparation and food preparation thereof (hereinafter also referred to as “composition”) of the present invention contain peanut and / or an extract thereof as active ingredients.
本発明の組成物によれば、悪液質の改善作用により、がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの疾患が悪液質状態までに進行することを防止するができる、と共に、悪液質状態を改善し、治療することもできる。 According to the composition of the present invention, the cachexia-improving action can prevent diseases such as cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis from progressing to the cachexia state. , And can improve and treat cachexia.
本発明の組成物は、例えば、悪液質改善治療製剤およびその食品製剤の有効成分として有用である。本発明の組成物によれば、優れた悪液質改善効果を有するうえに、重篤な副作用がない点で非常に有用である。以下、本発明の方法について具体的に説明する。 The composition of the present invention is useful, for example, as an active ingredient of a cachexia ameliorating therapeutic preparation and a food preparation thereof. The composition of the present invention is very useful in that it has an excellent cachexia improving effect and has no serious side effects. Hereinafter, the method of the present invention will be specifically described.
1.トウダイグサ科サピウム属の植物
本発明の組成物において原料として使用されるトウダイグサ科サピウム属(Euphobiaceae Sapium)の植物は、落葉または常緑の低木または高木である。トウダイグサ科サピウム属の植物は、東南アジアおよび中南米などの熱帯や亜熱帯に分布している。トウダイグサ科サピウム属の植物としては、例えば、ナンキンハゼが挙げられる。1. Euphorbiaceae Sapium plant used as a raw material in the composition of the present invention is a deciduous or evergreen shrub or tree. Plants of the genus Sapium are distributed in tropics and subtropics such as Southeast Asia and Central and South America. An example of a plant belonging to the genus Sapium of the Euphorbiaceae family is peanut.
トウダイグサ科サピウム属の植物を本発明の原料として使用する場合、その使用部位は特に限定されないが、例えば、果実、茎、根、根皮、花、種子、樹皮、樹脂、樹幹、木部、枝などを使用することができる。樹幹部または根部の表皮、柔組織、内皮、木部、篩部等の各部とも使用することができる。これらの素材は、湿潤状態および乾燥状態のいずれでもよい。また、溶媒によって抽出された抽出液、あるいはこの抽出液を乾燥させて得られる乾燥物を用いてもよい。 When a plant belonging to the genus Sapium is used as a raw material of the present invention, its use site is not particularly limited. For example, fruit, stem, root, root bark, flower, seed, bark, resin, trunk, xylem, branch Etc. can be used. It can also be used with various parts such as the trunk or root epidermis, soft tissue, endothelium, xylem, and sieve. These materials may be either wet or dry. Moreover, you may use the extract obtained by drying the extract extracted with the solvent, or this extract.
抽出用溶媒の種類としては、特に限定されないが、例えば、水、親水性有機溶媒、および親油性有機溶媒が挙げられる。親水性有機溶媒としては、メタノール、エタノール、プロパノール、ブタノールなどの低級アルコール類、ギ酸、酢酸などの有機酸類、ジメチルスルホキシド、フェノール類などが例示できる。これらのうち、食用に用いられる点で、水またはエタノールが好ましい。親油性有機溶媒としては、クロロホルム、ペンタン、ヘキサン、アセトン、酢酸エチル、アセトニトリル、ベンゼン、ならびにナタネ油などの植物油脂が例示できる。 Although it does not specifically limit as a kind of solvent for extraction, For example, water, a hydrophilic organic solvent, and a lipophilic organic solvent are mentioned. Examples of the hydrophilic organic solvent include lower alcohols such as methanol, ethanol, propanol and butanol, organic acids such as formic acid and acetic acid, dimethyl sulfoxide and phenols. Among these, water or ethanol is preferable in that it is used for food. Examples of the lipophilic organic solvent include chloroform, pentane, hexane, acetone, ethyl acetate, acetonitrile, benzene, and vegetable oils such as rapeseed oil.
ナンキンハゼ(南京黄櫨、学名:Sapium sebiferum(L.)Roxb.、
名:Vegetable tallow、または、Chinese tallow tree、または、Tallow tree、または、white wax berry、または、chicken tree、または、popcorn tree)は、中国原産のトウダイグサ科サピウム属落葉高木で、秋には菓が美しい赤紅色に色づき、街路樹や庭園樹として植栽されている。日本では、その乾燥根皮は利尿剤または下剤として利用され、その種子は蝋燭や石鹸の原料として利用されている。Nankin goby (Nanjing Huangpu, Scientific name: Sapium sebiferum (L.) Roxb.,
Name: Vegetable tall, Chinese tall tree, Tallow tree, white wax very, chicken tree, or popcorn tree Colored in beautiful red and red, it is planted as street trees and garden trees. In Japan, the dried root bark is used as a diuretic or laxative, and its seed is used as a raw material for candles and soaps.
ナンキンハゼを本発明の組成物の原料として使用する場合、その使用部位は特に限定されないが、例えば、根皮、根、茎、種子、実、葉、花、樹皮、樹脂、樹幹、木部、枝を使用することができる。樹幹部または根部の表皮、柔組織、内皮、木部、篩部等の各部とも使用することができる。また、本発明の組成物の原料として、ナンキンハゼから溶媒によって抽出された抽出液、あるいはこの抽出液を乾燥させて得られる乾燥物を用いてもよい。ナンキンハゼおよび/またはその抽出物をヒトが摂取した場合、下痢が生じることがあるが、約半日位経つと回復する。その他に副作用はなく、毒性もない。 When peanut is used as a raw material of the composition of the present invention, the use site is not particularly limited. For example, root bark, root, stem, seed, fruit, leaf, flower, bark, resin, trunk, xylem, branch Can be used. It can also be used with various parts such as the trunk or root epidermis, soft tissue, endothelium, xylem, and sieve. Further, as a raw material of the composition of the present invention, an extract extracted from a groundnut with a solvent or a dried product obtained by drying the extract may be used. When humans ingest peanut and / or its extract, diarrhea may occur, but it will recover after about half a day. There are no other side effects and no toxicity.
ナンキンハゼの抽出物の製造方法(有効成分の抽出方法)としては、特に限定されないが、例えば、ナンキンハゼの新鮮根皮、或いは乾燥根皮を蒸留水に浸して、低温にて数分間ないし数十時間以上静置する方法が挙げられる。その他の抽出物の製造方法としては、例えば、熱水抽出法や溶媒抽出法が挙げられる。 The method for producing the extract of peanut (the extraction method of the active ingredient) is not particularly limited. For example, a fresh root bark or dried root bark of peanut is soaked in distilled water, and the temperature is low for several minutes to several tens of hours. The method of leaving still above is mentioned. Examples of other methods for producing the extract include a hot water extraction method and a solvent extraction method.
2.悪液質改善作用の評価方法
本発明の組成物における悪液質改善作用の評価としては、公知の方法であるヒトを対象とした評価方法と担がん動物モデルを対象とした評価方法を用いることができる。ヒトを対象とした評価方法としては、臨床指標からの評価方法と生化学的指標からの評価方法がある。2. Evaluation method of cachexia improving action As an evaluation of cachexia improving action in the composition of the present invention, a known method for evaluating humans and an evaluation method for cancer-bearing animal models are used. be able to. As evaluation methods for human subjects, there are an evaluation method based on clinical indicators and an evaluation method based on biochemical indicators.
臨床指標としては、特に限定されるわけではないが、主として、食欲不振、倦怠感、るいそう、体重の減少等の症状がよく用いられる(非特許文献6)。 Although it does not necessarily limit as a clinical parameter | index, Symptoms, such as anorexia, a malaise, a tingle, a weight loss, are often used mainly (nonpatent literature 6).
生化学的指標としては、特に限定されるわけではないが、TNF−α、IFN、IL−6が挙げられる。 Biochemical indicators include, but are not limited to, TNF-α, IFN, and IL-6.
この他、血漿カルシウム濃度と血糖値も評価指標として用いられることがある。 In addition, plasma calcium concentration and blood glucose level may be used as evaluation indexes.
本発明は、先ず、ヒトを対象に臨床指標から評価を行った。 In the present invention, first, humans were evaluated from clinical indices.
がんおよび腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの疾患が進行すると、体液、特に血液中にトキソホルモン(toxohormone)を始め、TNF−α、IFN、IL−6などのいろいろな種類のサイトカインが上昇し、食欲関連ホルモン(グレリン、レプチン)が低下し、食欲不振を惹起する。また、視床下部における摂食抑制ニューロン活動の増加、摂食促進ニューロン活動の減少、迷走神経経路による胃の運動と分泌機能の抑制も食欲不振を惹起している。 As diseases such as cancer and tumor, diabetes, endocrine disease, blood system disease, tuberculosis progress, various types such as TNF-α, IFN, IL-6, including toxohormones in body fluids, especially blood Cytokines increase, appetite-related hormones (ghrelin, leptin) decrease, and anorexia occurs. In addition, an increase in feeding inhibitory neuron activity in the hypothalamus, a decrease in feeding promoting neuron activity, and suppression of gastric motility and secretory function through the vagus nerve pathway also cause anorexia.
食欲不振は体重の減少、るいそう、倦怠感、ゆえに日常行動能力の低下を引き起こす。 Loss of appetite causes weight loss, tingling, malaise, and thus a decrease in daily behavioral ability.
食欲の改善並びに体重の増加、日常行動能力の回復は、悪液質の改善、または悪液質からの脱出(治癒)として評価されている。 Improvement of appetite and weight gain, recovery of daily behavioral ability are evaluated as improvement of cachexia or escape from cachexia (healing).
3.悪液質改善作用に関する用途
がん(cancer)は大別して、造血器由来のがんと、上皮細胞からなる癌(carcinoma)と、非上皮性細胞からなる肉腫(sarcoma)とに分類される。造血器由来のがんとしては、例えば、白血病、悪性リンパ腫、骨髄腫などが挙げられる。上皮細胞由来の癌としては、例えば、肺癌、乳癌、胃癌、大腸癌、子宮癌、卵巣癌、頭頚部の癌(喉頭癌、咽頭癌、舌癌など)などが挙げられる。また、肉腫としては、例えば、骨肉腫、軟骨肉腫、横紋筋肉腫、平滑筋肉腫、線維肉腫、脂肪肉腫、血管肉腫などが挙げられる。3. Applications related to cachexia-improving action Cancers are roughly classified into hematopoietic cancer, carcinoma composed of epithelial cells, and sarcoma composed of non-epithelial cells. Examples of hematopoietic cancer are leukemia, malignant lymphoma, myeloma, and the like. Examples of the cancer derived from epithelial cells include lung cancer, breast cancer, stomach cancer, colon cancer, uterine cancer, ovarian cancer, head and neck cancer (laryngeal cancer, pharyngeal cancer, tongue cancer, etc.) and the like. Examples of the sarcoma include osteosarcoma, chondrosarcoma, rhabdomyosarcoma, leiomyosarcoma, fibrosarcoma, liposarcoma, and angiosarcoma.
本発明の組成物は、あらゆる末期がんに対して抗悪液質作用を発揮することができる。すなわち、本発明の組成物の対象となる末期がんとしては、例えば、悪性リンパ腫(ホジキンリンパ腫、非ホジキンリンパ腫など)、胃がん、陰茎がん、咽頭がん(上咽頭がん、中咽頭がん、下咽頭かんなど)、外陰がん、下垂体線腫、肝細胞がん、胸腺腫、菌状息肉症、原発不明がん、骨髄異形成症候群、子宮がん(子宮頚部がん、子宮体部がん、子宮肉腫など)、絨毛性疾患、食道がん、腎孟がん、尿管がん、神経膠腫、腎細胞がん、膵がん、膵内分泌腫瘍、精巣腫瘍、前立腺がん、大腸がん、多発性骨髄腫、胆管がん、胆嚢がん、膣がん、中皮腫、聴神経鞘腫、軟部肉腫、乳がん、脳腫瘍、肺がん、白血病(急性骨髄性白血病、急性リンパ性白血病、成人T細胞白血病リンパ腫、慢性骨髄性白血病、慢性リンパ性白血病など)、皮膚がん(悪性黒色腫など)、膀胱がん、慢性骨髄増殖性疾患、卵巣がん、卵巣胚細胞腫瘍が挙げられる。 The composition of the present invention can exert an anti-cachexia effect on any terminal cancer. That is, examples of terminal cancers to which the composition of the present invention is applied include malignant lymphoma (Hodgkin lymphoma, non-Hodgkin lymphoma, etc.), gastric cancer, penile cancer, pharyngeal cancer (nasopharyngeal cancer, oropharyngeal cancer). , Hypopharyngeal canal, etc.), vulvar cancer, pituitary fibroma, hepatocellular carcinoma, thymoma, mycosis fungoides, cancer of unknown primary origin, myelodysplastic syndrome, uterine cancer (cervical cancer, uterine body) Cancer, uterine sarcoma), chorionic disease, esophageal cancer, renal pelvic cancer, ureteral cancer, glioma, renal cell cancer, pancreatic cancer, pancreatic endocrine tumor, testicular tumor, prostate cancer , Colorectal cancer, multiple myeloma, bile duct cancer, gallbladder cancer, vaginal cancer, mesothelioma, acoustic schwannoma, soft tissue sarcoma, breast cancer, brain tumor, lung cancer, leukemia (acute myeloid leukemia, acute lymphoblastic leukemia) Adult T-cell leukemia / lymphoma, chronic myeloid leukemia, chronic lymphocytic leukemia) (Malignant melanoma, etc.), bladder cancer, chronic myeloproliferative diseases, ovarian cancer, ovarian germ cell tumor.
さらに、糖尿病、内分泌疾患、血液系疾患、結核などの疾患の悪液質状態においても抗悪液質作用を発揮することができる。 Furthermore, it can exert an anti-cachexia effect even in the cachexia state of diseases such as diabetes, endocrine disease, blood system disease, tuberculosis and the like.
本発明の組成物を悪液質改善治療製剤として用いる場合、他の抗がん剤と併用することができる。この場合、本発明の組成物を、免疫機能を増強させるインターフェロンやサイトカイン類と併用することができる。 When the composition of the present invention is used as a cachexia improving therapeutic preparation, it can be used in combination with other anticancer agents. In this case, the composition of the present invention can be used in combination with interferons or cytokines that enhance the immune function.
さらに、本発明の組成物を、例えば、シスプラチン、カルボプラチン、オキザロプラチン、マイトマイシン、ブレオマイシン、アドリアマイシン、5−フルオロウラシル、タキソールなどの他の抗がん剤と併用したり、あるいは放射線治療と併用したりすることもできる。 Furthermore, the composition of the present invention is used in combination with other anticancer agents such as cisplatin, carboplatin, oxaloplatin, mitomycin, bleomycin, adriamycin, 5-fluorouracil, taxol, or in combination with radiation therapy. You can also
本発明の組成物を悪液質改善治療製剤として用いる場合、他の植物性薬草(生薬や漢方薬など)と併用することができる。 When the composition of the present invention is used as a cachexia ameliorating therapeutic preparation, it can be used in combination with other botanical herbs (herbal medicine, herbal medicine, etc.).
植物性薬草としては、特にこれに限定されるものではないが、例えば、アイ草(アイソウ)、アカザ、アカネ根(アカネコン)、赤目柏(アカメガシワ)、アガリクス、阿膠(アキョウ)、山東阿膠(サントウアキョウ)、ゼラチン、アケビの実(木通子、モクツウシ)、アケビの蔓性茎(木通、モクツウ)、アシタバ、アスナロ葉(アスナロヨウ)、甘茶(アマチャ)、アマチャヅル、亜麻仁(アマニン)、アワビ類の殻(石決明、セッケツメイ)、郁李仁(イクリニン)、イズイ(アマドコロ)、一位(アララギ、イチイ)、イチヂクの実(イチヂクノミ)、イチヂク葉(イチヂクヨウ)、イチョウ、稲苗(イネナエ)、威霊仙(イレイセン)、岩千舎(イワジシャ)、岩蕗(イワブキ)、茵陳蒿(インチンコウ)、綿茵陳(メンインチン)、淫羊霍(イカリ草、インヨウカク)、茴香(ウイキョウ)、宇金(ウコン)、烏頭(ウズ)、烏棗(ウソウ)、烏賊骨(ウゾッコツ)、烏梅(ウバイ)、烏薬(ウヤク)、ウツボグサ(夏枯草、カゴソウ)、兎余糧(ウヨリョウ)、裏白樫(ウラジロガシ)、営実(エイジツ)、延胡索(エンゴサク)、延命草(エンメイソウ)、黄耆(オウギ)、オウゴン、黄精(オウセイ)、黄土(オウド)、黄柏(オウバク)、桜皮(オウヒ)、王不留行(オウフルギョウ)、黄連(オウレン)、オオツヅラフジ(防已、ボウイ)、オオバコの種子(車前子、シャゼンシ)、オオバコの全草(車前草、シャゼンソウ)、弟切草(オトギリソウ)、遠志(オンジ)、カイカ、海金砂(カイキンシャ)、懐牛膝(カイゴシツ)、芥子(ガイシ)、白芥子(ハクガイシ)、海松子(カイショウシ)、海桐皮(カイドウヒ)、マクリ、海人草(カイニンソウ)、薤白(ガイハク)、艾葉(ガイヨウ)、ヨモギ、カキドオシ、連銭草(レンセンソウ)、柿の葉(カキノハ)、柿(カキ)のへた、柿蔕(シテイ)、夏枯草(カゴソウ)、訶子(カシ)、何首烏(カシュウ)、莪朮(ガジュツ)、カッコウ、葛根(カッコン)、滑石(カッセキ)、カミツレ、カヤツリ草(ソウ)、カヤの実、ガラナ、訶り勒(カリロク)、訶子(カシ)、花梨の実(カリンノミ)、木瓜(モッカ)、カ楼根(カロコン)、カ楼実(カロジツ)、カ楼仁(カロニン)、川柳(カワヤナギ)、カワラタケ(寄性竹、キセイタケ)、カワラヨモギ(茵陳蒿、インチンコウ)、乾姜(カンキョウ)、貫衆(カンジュウ)、貫仲(カンチュウ)、甘草(カンゾウ)、款冬花(カントウカ)、款冬根(カントウコン)、旱蓮草(カンレンソウ)、桔梗、菊花(キクカ)、杭菊花(コウキッカ)、枳子(キグシ)、枳殻(キコク)、キササゲ、枳実(キジツ)、寄性(キセイ)、桑寄性(ソウキセイ)、寄性茶(キセイチャ)、寄性竹(キセイタケ)、北沙参(キタシャジン)、吉草根(キッソウコン、カノコソウ、橘皮(キッピ)、キハダ(黄柏、オウバク)、亀板(キバン)、ギムネマシルベスタ、胡瓜蔓(キュウリヅル)、羌活(キョウカツ)、和羌活(ワキョウカツ)、杏仁(キョウニン)、イズイ(玉竹、ギョクチク)、キラン草(キランソウ)、金桜子(キンオウシ)、金柑(キンカン)、金銀花(キンギンカ)、銀柴胡(ギンサイコ)、金針菜(キンシンサイ)、金銭草(キンセンソウ)、キンミズヒキ、仙鶴草(センカクソウ)、グアバの実(蕃果バンカ)、枸杞子(クコシ)、枸杞の実(クコノミ)、枸杞の根皮(地骨皮、ジコッピ)、枸杞葉(クコヨウ)、苦参(クジン)、クズの根(葛根、カッコン)、狗脊(クセキ)、クチナシ、瞿麦(クバク)、熊笹(クマザサ)、熊柳(クマヤナギ)、クルミ、苦棟皮(クレンピ)、黒文字(クロモジ)、桑茶(クワチャ)、桑の葉(クワノハ)、桑の実(クワノミ)、荊芥(ケイガイ)、鶏血藤(ケイケットウ)、桂枝(ケイシ)、桂皮(ケイヒ)、月桂樹葉(ゲッケイジュヨウ)、ケツメイシ、毛人参(ケニンジン)、牽牛子(ケンゴシ)、ケン実(ケンジツ)、拳参(ケンサン)、玄参(ゲンジン)、ゲンノショウコ、膠飴(コウイ)、麦芽糖化飴(バクガトウカトウ)、紅花(コウカ)、合歓皮(ゴウカンヒ)、杭菊花(コウキクカ)、降香(コウコウ)、香シ(コウシ)、香需(コウジュ)、紅参(コウジン)、香附子(コウブシ)、粳米(コウベイ)、厚朴(コウボク)、厚朴実(コウボクジツ)、蒿本(コウホン)、牛黄(ゴオウ)、エゾウコギ(五加参、ゴカジン)、五加皮(ゴカヒ)、牛膝(ゴシツ)、呉茱萸(ゴシュユ)、骨砕補(コッサイホ)、クルミ(胡桃肉、コトウニク)、五倍子(ゴバイシ)、琥珀(コハク)、牛蒡子(ゴボウシ)、胡麻(ゴマ)、五味子(ゴミシ)、胡盧巴(コロハ)、柴胡(サイコ)、柴胡木(サイコボク)、細辛(サイシン)、ザクロ果皮(石榴果皮、セキリュウカヒ)、サフラン、鎖陽(サヨウ)、山査子(サンザシ)、山査肉(サンザニク)、山慈姑(サンジコ)、山梔子(サンシシ)、蚕砂(サンシャ)、山茱萸(サンシュユ)、山椒(サンショウ)、山豆根(サンズコン)、酸棗仁(サンソウニン)、山扁豆(サンペンズ)、山薬(サンヤク)、三稜(サンリョウ)、地黄(ジオウ)、熟地黄(ジュクジオウ)、紫苑(シオン)、紫花地丁(シカジチョウ)、絲瓜絡(シカラク)、エゾウコギ(刺五加、シゴカ)、地骨皮(ジコッピ)、紫根(シコン)、軟紫根(ナンシコン)、磁石(ジセキ)、紫石英(シセキエイ)、紫蘇子(シソシ)、シツ梨子(シツリシ)、地膚子(ジフシ)、炙甘草(シャカンゾウ)、赤石脂(シャクセキシ)、芍薬(シャクヤク)、大和芍薬(ヤマトシャクヤク)、蛇床子(ジャショウシ)、沙参(シャジン)、北沙参(キタシャジン)、車前子(シャゼンシ)、シャ虫(シャチュウ)、充慰子(ジュウイシ)、修治附子(シュウジブシ)、ジュウヤク、ドクダミ、縮砂(シュクシャ)、棕呂実(シュロジツ)、棕呂葉(シュロヨウ)、生姜(ショウキョウ)、松脂(ショウシ)、小麦(ショウバク)、菖蒲根(ショウブコン)、升麻(ショウマ)、椒目(ショウモク)、小連翹(ショウレンギョウ)、女貞子(ジョテイシ)、地竜(ジリュウ)、辛夷(シンイ)、晋耆(シンギ)、神麹(シンギク)、ジンギョウ、イカズラの茎葉、忍冬(ニンドウ)、スイカズラの花(金銀花、キンギンカ)、水蛭(スイテツ)、スギナ、豆鼓(ズシ)、香鼓(コウシ)、青ソウ子(セイソウシ)、青黛(セイタイ)、青皮(セイヒ)、西洋人参(セイヨウニンジン)、赤芍(セキシャク、石菖根(セキショウコン)、石松子(セキショウシ)、石榴果皮(セキリュウカヒ)、石決明(セッケツメイ)、石膏(セッコウ)、石斛(セッコク)、ニワトコ、接骨朴(セッコツボク)、仙鶴草(センカクソウ)、全蝎(ゼンカツ)、川キュウ(センキュウ)、川玉金(センギョクキン)、前胡(ゼンコ)、川穀(センコク)、川骨(センコツ)、川膝(センシツ)、茜草、センソウコン)、蝉退(センタイ)、センナ、川貝(センバイ)、旋覆花(センプクカ)、センブリ、仙茅(センボウ)、川連子(センレンシ)、草果(ソウカ)、皀角刺(ソウカクシ)、皀角子(ソウカクシ)、皀莢(ソウキョウ)、桑の実(桑椹子、ソウジンシ)、蒼耳子(ソウジシ)、蒼朮(ソウジュツ)、草荳(ソウズク)、桑白皮(ソウハクヒ)、桑ヒョウ蛸(ソウヒョウショウ)、桑葉(ソウヨウ)、桑の葉(クワノハ)、側柏葉(ソクハクヨウ)、蘇木(ソボク)、蘇葉(ソヨウ)、大茴香(ダイウイキョウ)、大黄(ダイオウ)、大海子(ダイカイシ)、大根草(ダイコンソウ)、ダイコンの種子(羅葡子、ラブシ)、代赭石(タイシャセキ)、大青葉(ダイセイヨウ)、大棗(タイソウ)、大腹皮(ダイフクヒ)、高遠草(タカトウグサ)、沢瀉(タクシャ)、沢蘭(タクラン)、ターメリック、タラ根皮(タラコンピ)、丹参(タンジン)、淡竹葉(タンチクヨウ)、竹葉(チクヨウ)、タンポポの根(蒲公英根、ホコウエイコン)、タンポポ(蒲公英、ホコウエイ)、竹茹(チクジョ)、竹節人参(チクセツニンジン)、竹葉(チクヨウ)、知母(チモ)、茶葉(チャヨウ)、地楡(チユ)、丁香(チョウコウ)、丁字(チョウジ)、釣藤鈎(チョウトウコウ)、猪牙皀莢(チョガソウキョウ)、猪苓(チョレイ)、陳皮(チンピ)、ツチアケビ(土通草、ドツウソウ)、露草(ツユクサ)、ツルドクダミの根、熟何首烏(ジュクカシュウ)、ツルナ、浜千舎(ハマジシャ)、テイレキシ、天竺黄(テンジクオウ)、天南星(テンナンショウ)、天麻(テンマ)、天木実(テンモクジツ)、天木蔓(テンモクツル)、天門冬(テンモンドウ)、冬瓜子(トウガシ)、当帰(トウキ)、冬癸子(トウキシ)、唐胡麻(トウゴマ)、灯芯草(トウシンソウ)、党参(トウジン)、刀豆(トウズ)、冬虫夏草(トウチュウカソウ、唐独活(トウドクカツ)、桃仁(トウニン)、橙皮(トウヒ)、当薬(トウヤク)、センブリ、土瓜根(ドカコン)、土瓜実(ドカジツ)、独活(ドクカツ)、ドクダミ(ジュウヤク)、兎糸子(トシシ)、栃の実(トチノミ)、社仲(トチュウ)、土通草(ドツウソウ)、土茯苓(ドブクリョウ)、山帰来(サンキライ)、土別甲(ドベッコウ)、別甲(ベッコウ)、鳥不止(トリトマラズ)、目木(メギ)、トンブリ、地膚子(ジフシ)、ナズナ、ナタマメ(白刀豆、ハクトウズ)、ナツメ、ナツメグ、肉豆(ニクズク)、ナルコユリの地下茎(黄精、オウセイ)、軟紫根(ナンシコン)、南天実(ナンテンジツ)、南天葉(ナンテンヨウ)、南蛮毛(ナンバンゲ)、苦木(ニガキ)、肉ジュヨウ(ニクジュヨウ)、錦木(ニシキギ)、乳香(ニュウコウ)、ニワトコ、ニワトコ葉(ヨウ)、ニンジン、白参(ハクジン)、忍冬(ニンドウ)、ネズの実(杜松子、トショウシ)、ネズミモチ、女貞子(ジョテイシ)、貝母(バイモ)、麦芽(バクガ)、白芥子(ハクガイシ)、柏子仁(ハクシニン)、白荳(ハクズク)、白鮮皮(ハクセンピ)、白頭翁(ハクトウオウ)、白桃花(ハクトウカ)、白刀豆(ハクトウズ)、白南天(シロナンテン)、南天実(ナンテンジツ)、白扁豆(ハクヘンズ)、麦門冬(バクモントウ)、巴戟天(ハゲキテン)、破胡紙(ハコシ)、ハコベ、芭蕉根(バショウコン)、ハスの実、八角(ハッカク)、大茴香(ダイウイキョウ)、ハト麦、炮じハト麦、ハナモツ、ハブ草、炮じハブ茶、浜千舎(ハマジシャ)、浜防風(ハマボウフウ)、蕃果(バンカ)、半夏(ハンゲ)、バンザクロの葉、グアバ葉、半枝連(ハンシレン)、蕃石榴葉(バンセキリュウヨウ)、グアバ葉、胖大海(ハンタイカイ)、大海子(ダイカイシ)、板藍根(バンランコン)、ヒカイ、彼岸花(ヒガンバナ)、ヒキオコシ(延命草、エンメイソウ)、菱の実(ヒシノミ)、干葉(ヒバ)、ヒ麻子(ヒマシ)、唐胡麻(トウゴマ)、百合(ビャクゴウ)、白シ(ビャクシ)、白朮(ビャクジュツ)、白檀(ビャクダン)、白薇(ビャクビ)、百部根(ヒャクブコン)、白花蛇舌草(ビャッカジャゼツソウ)、白キュウ(ビャッキュウ)、白僵蚕(ビャッキョウサン)、ヒル、水蛭(スイテツ)、枇杷葉(ビワヨウ)、びわの葉、檳榔子(ビンロウジ)、覆盆子(フクボンシ)、茯苓(ブクリョウ)、附子(ブシ)、紅ざらさ(ベニザラサ)、扁蓄(ヘンチク)、防已(ボウイ)、茅根(ボウコン)、虻虫(ボウチュウ)、防風(ボウフウ)、炮附子(ホウブシ)、蒲黄(ホオウ)、撲ソク(ボクソク)、補骨脂(ホコツシ)、破胡紙(ハコシ)、牡丹皮(ボタンピ)、牡蠣(ボレイ)、瑰花(マイカイカ)、麻黄(マオウ)、去節麻黄(キョセツマオウ)、麻黄根(マオウコン)、マクリ(海人草、マクリ)、麻子仁(マシニン)、マタタビの蔓(ツル)、天木蔓(テンモクツル)、マタタビの実、天木実(テンモクジツ)、松の実(マツノミ)、海松子(カイショウシ)、松葉(マツバ)、松藤(マツフジ)、マツヤニ、松脂(ショウシ)、蔓荊子(マンケイシ)、密蒙花(ミツモウカ)、ミツロウさらし蜜蝋、ミロバラン、訶子(カシ)、イチヂク実(無花果、ムカカ)、イチヂク葉、めぐすりの木、綿茵陳(メンインチン)、木賊(モクゾク)、木通(モクツウ)、木通子(モクツウシ)、木天蓼(モクテンリョウ)、マタタビの実の虫瘤(ムシコブ)、木瓜(モッカ)、木香(モッコウ)、桃の葉(モモノハ)、スギナ、門荊(モンケイ)、射干(ヤカン)、益智(ヤクチ)、益智仁(ヤクチニン)、益母草(ヤクモソウ)、夜交藤(ヤコウトウ)、矢車実(ヤシャジツ)、八ツ目蘭(ヤツメラン)、熊胆(ユウタン)、雪の下(ユキノシタ)、ユズリ葉、ユリ根(百合、ビャクゴウ)、ヨクイニン、雷丸(ライガン)、莱フク子(ライフクシ)、羅葡子(ラブシ)、羅漢果(ラカンカ)、李根皮(リコンピ)、竜眼肉(リュウガンニク)、劉寄奴(リュウキド)、竜骨(リュウコツ)、竜胆(リュウタン)、良姜(リョウキョウ)、緑豆(リョクズ)、霊芝(レイシ)、連翹(レンギョウ)、連銭草(レンセンソウ)、蓮肉(レンニク)、鹿茸(ロクジョウ)、露蜂房(ロホウボウ)、路路通(ロロツウ)、和羌活(ワキョウカツ)などが挙げられる。 Examples of plant medicinal herbs include, but are not limited to, for example, eye grass (Iso), red aza, red root (Akanekon), red eyed (Akamegashiwa), agaricus, Aki, Santou Akyo), gelatin, akebi fruits (Kitsuko, Mokutsuushi), akebi vine stems (Kitsuji, Mokutsu), Ashitaba, Asunaro leaves (Asunaroyou), Achacha (Amacha), Achacharu, Flaxseed (Amanin), Abalone Shell (Ishimei, Sekitsukeme), Yurijin (Iklinin), Izui (Amadokoro), 1st place (Araragi, Yew), Fig fruit (Yichijinomi), Fig leaf (Yichijiyo), Ginkgo, Ina seedling (Inenae), Wei Reisen, Iwajisha, Iwabuki, Inchinkou, Menchiin ), Lewd sheep squid (Ikari grass, Yinokukaku), licorice (Yukoku), Ujin (turmeric), quail (Uzuku), 烏 棗 (Uso), bandit bone (Usokkotsu), 烏 ume (Ubai), glaze (Uyaku) , Peony (summer hay, kagosou), surplus food (agaric), back white coral (bill beetle), fruit (age), engorgone, longevity (engaiso), jade (ogi), ogon, yellow spirit , Ocher, yellow duck, cherry bark (Ohhi), wandering (Ohulgyo), Hou Ren (Ouren), Otsu Rafuji (prevented, Bowie), psyllium seeds (carlet, Chazenshi) , Psyllium whole plant (pre-cursor), younger brother (hypergum), distant (onji), kaika, kaikin sand (kaikinsha), kaishi knee (kaigoshitsu), lion (Hakugaishi), Kaimatsuko (Kaishoushi), Sea paulownia bark (Kaidohushi), Makuri, Kaijinso (Kinoshiku), Bakuhaku (Gaihaku), Yakugi (Gaiyou), Mugwort, Kakidooshi, Reindeer (Rensenso), Bamboo leaves (Kakinoha), oyster (Kakinoha), cocoon (Kite), summer hay (Kagosou), lion (Kashi), how many 烏 (Kashu), 莪 朮 (Gadju), cuckoo, kakkon (Kakkon), talc (Kasseki) ), Chamomile, cypress grass (saw), kaya fruit, guarana, potato (kaliroku), coconut (oak), quince fruit (carinomi), mushroom (mokka), karo root (caloron), calf Berries (Karojintsu), Kawaro Jin (Karoin), Kawayanagi (Kawayanagi), Kawaratake (parusal bamboo, Kiseitake), Kawara mugwort (Kin Chen, Inchinkou), Inui (Kankyo), Kanshu, Kanchu ( Licorice, licorice, licorice winter flower, licorice root root, licorice, bellflower, chrysanthemum flower, chrysanthemum flower, kikushi, chrysanthemum husk ), Kisame, Kakitsu, Koji, Kuwayose, Kosecha, Bamboo Bamboo, Kitasashajin, Valerian, Ganoderma Tachibana bark (Kippi), yellowfin (yellow tuna, amber), turtle plate (kiban), gymnema sylvestre, cucumber vine (cucumber), katsukatsu (Kyokatsu), Japanese kite (Kyokatsu), apricot (Kyonin), Izui (Tamatake, Gokukiku) ), Kiran grass, Golden cherry, Kinkan, Kinginka, Ginsai, Kinshinsai , Money grass, goldfish, senkakuso, guava fruit (bamboo bunka), coconut fruit, cucumber fruit seedling, bark root bark (earthbone bark, dicoppi), cocoon Leaves (Kukoyo), bitter ginseng (kujin), kuzu roots (kudzu, kakkon), spinach (kuseki), gardenia, buckwheat (kubaku), kumaraku (kumazasa), kumayanagi (beard willow), walnut, bitter skin ( Krempi), black letters (Kuromoji), mulberry tea (Kwacha), mulberry leaves (Kwanoha), mulberry seeds (Kwanomi), cocoon (Kai-Gai), chicken blood wisteria (Kaiketto), katsura (Keishi), cinnamon (Keihi) , Bay bay leaves, beetle, ginseng, kenshishi, kenji, kensan, ginseng, ginseng, gauze, maltose飴 (Bakugatokatou), safflower (Kouka), communal skin (Gankanhi), stake chrysanthemum (Koukikuka), incense (Koukou), incense (Koushi), incense demand (Kouju), red ginseng (Koujin), incense (Kobushi) ), Glutinous rice (Koubay), Koboku, Kobokujitsu, Kouhon, Gyuhuang, Ekokogi (Gokajin, Gokajin), Gokahi (Gokahi), cow knee ( Goshitsu), Kureyu, Kossaiho, Walnut (Peanut, Kotoniku), Pyrup (Gobai), Kaki, Gyudon, Sesame (Goma), Gomi (Goshi), Pepper (Koroha), Saiko (Psycho), Saiko (Psychoboku), Spicy (Saishin), Pomegranate peel (Ishizuchi pericarp, Sekiryukahi), Saffron, Sayo (Sayo), Yamasuko (Hawthorn), Yamasane Meat Zanik), Sanji-ko, Sanshishi, Sansha, Sanshuyu, Sansho, Sanzukon, Sunzukon, Sanso-nin, Sanbong, Sanyaku, Sanryo, Jio, Jukujio, Shion, Shikajicho, Shikaku, Ekokogi (Sashigaoka, Shigoka), Earth bone skin (jicoppi), purple root (shikon), soft purple root (nanshikon), magnet (diseki), purple quartz (shisekiei), shisoko (shisoshi), shitsuriko (shitsurishi), saiko (jifushi), licorice licorice (Shakanzou), Akaishi fat (Shakuseki), Shakuyaku, Yamato Shakuyaku, Serpentine (Jashobushi), Sasang (Shajin), Kitasashin (Kitashajin), Maeko (Shazenshi), Sha insect (Shachu), Amiko (Shujibushi), Shujibushi (Shujibushi), Zyuyaku, Dokudami, Shredded sand (Shukusha), Minoru Minoru (Shorotsu), Guro leaf (Shuroyo), Ginger (Chrysanthemum), pine resin (Choushu), wheat (Ginger), Sone (Ginger), urn (Ginger), moth (Ginger), Xiao Lian (Ginger), Sadako (Gyotoshi), ground dragon ( Jiryu), bonito, shingi, shingi, gentian, lizard stems and leaves, ninja winter, honeysuckle flowers (gold and silver flowers, goldfish), syringa, cedar, bean drum (Zushi), Drum (Koushi), Blue Saw (Seisoushi), Aoi (Seitai), Aoi (Seishi), Western ginseng (Carrot), Red fox (Sekishak, Stone) Root (Sekishokon), Ishimatsuko (Sekishoushi), Ishizuku pericarp (Sekiryu Kahi), Ishidake (Sekkotsumei), Gypsum (Sekko), Seiko (Sekkoku), Elderberry, Bone (Sekitsukoku), Senkakuso (Senkakoku), All Zenkatsu, River Kyu (Senkyu), Kawadamakin (Zenkoku), Maehu (Zenko), River grain (Senkok), River bone (Senktsu), River knee (Senshitsu), Reed grass, Sensokon), Regression ( Sentai), senna, Kawakai (Senbai), whirling flower (Senpukuka), assembly, Sensen (Senbou), Kawarenko (Senrenshi), grass (Souca), Sakukaku (Sokukakushi), Sakakuko (Sokukakushi) , Persimmon (mushroom), mulberry seed (mulberry coconut, cinnamon), crow ear (mushroom), persimmon (mushroom), grass moth (sowbill), mulberry white skin (sohakuhakuhi), mulberry leopard Persimmon (snow leopard), mulberry leaves (souyou), mulberry leaves (kuwanoha), foliage leaves (sakuhakuyo), sugi (soboku), soba (seoyo), daisyouka (daiwikyo), daihuang (daio), Daikaishi, Daikon grass, Japanese radish seeds (Rashiko, Rabushi), Daiseki, Taiseki, Daiiso, Daisaku, Daifukuhi, Takatogusa, Takusha, Takuran, Turmeric, Cod root bark (Taracompi), Dansang (Tangjin), Pale bamboo leaf (Tankukuyo), Bamboo leaf (Chikuyo), Dandelion root (Hokoeikon), Dandelion (Hong Kong, Hokoei), Chikujo, Chikujinjinjin, Bamboo leaves, Chimo, Tea leaves, Tea leaves Yu), Ding Chou (Chow), Ding Chou (Chou Ji), Choo Sung (Chow To Kou), Cang Tang (Cho Lei), Chin (Chinpi), Prickly Pear (Doutsu Grass, Dotsu Sou), Rust ( Tsuyukusa), Tsurudokudami root, Jukukashu, Tsuruna, Hamasensha, Teirexi, Tenjikuo, Tennansho, Tenma, Tenmokujitsu, Tenmokutsuru (Tenmokuru), Tenmon Fuyu (Tenmondou), Fuyu Toshi (Togashi), Toki (Touki), Fuyu Toshi (Toxi), Kara Sesame (Toshigoma), Lantern Grass (Toujinso), Ginseng (Toujin), Katana Beans (Tows), Cordyceps (Cultiva spruce), Tokatsu Katsu (Tokudokukatsu), Taojin (Tounin), Orange peel (Spruce), This medicine (Toyaku), Assembly, Earthenware Dokakon, Dokajitsu, Dokatsu, Dokudami, Toshishi, Tochinomi, Tochu, Tochu, Dotsuso (Bukryu), mountain return (Sankirai), Dobeckou (Becko), Bekkou (Betkko), bird-stopper (Tritomarazu), Megi (Japanese barberry), Tomburi, Chikiko (Jifushi), Nazuna, Natsume (white sword beans, Hakutozu), jujube, nutmeg, meat beans (Nikuzuk), Narukoyuri's rhizome (yellow spirit, horsetail), soft purple root (nanxikon), Nantenji (nantenjitsu), Nantenyo (nantenyou), Nanshige (nanbange), Nagi (nigaki) ), Meat Juyo (Nikujuyo), Nishiki (Nishikigi), Nukako (Nyuko), Elderberry, Elderberry Leaf (Yo), Carrot, White Ginseng (Hakujin), Shinobi Winter (Nindo) ), Rat seeds (Matsuko, Toshoushi), mouse mochi, female Sadako (Jotei), shellfish (Baimo), malt (Bakuga), white lion (Hakugaishi), lion Jin (Hakushinin), white shark (Hakuzuku), white Fresh skin (Hakusenpi), bald eagle (Hakutou), white peach blossom (Hakutouka), white sword bean (Hakutozu), white southern heaven (Shironanten), Nantenji (nantenjitsu), white pea (Hakuhenzu), barley winter (Bakumontou), 巴Bald tempura, shredded paper, boxfish, radish root, lotus seeds, octagonal, daikon kyoto, pigeon, sardine pigeon, hanamotsu, hub grass, Koji hub tea, Hama Sensha (Hamajisha), Hamabofu (Hanbofu), 蕃 果 (Bangka), Hanka, Banzakuro leaf, Guava leaf, Hanamuren, Hanshiren (Banse) Ryuyo), guava leaves, hantaikai, daikaishi, banyankon, hikai, cluster amaryllis (higanbana), hikikoshi (long life grass, enmeisou), hinoki (hishinomi), dried leaves (hiba), Cinnamon, Castor Sesame, Lily, Sandalwood, Sandalwood, Sandalwood, Sandalwood, Hyakubukon, White Flower Serpentine (Bicaccia japonicum), white cucumber (Biacukyu), white birch (Biakyokusan), hill, syrup (Sweet), birch leaf (Biwayo), loquat leaf, coconut (Binrouji), bonsai (Fukubonshi),茯苓 (Bukuryo), Tsutsumi (Bushi), Red Roughness (Benizarasa), Osamu (Henchiku), Prevention (Bouui), Sone (Boukon), Worm (Bouchi) C), Windproof (Bow Fu), Bamboo (Hubushi), Huang Hou (Hou), Waku Sok (Bokukoku), Bonebone Oil (Hakotsushi), Wuhu Paper (Hakoshi), Peony Skin (Boppi), Oyster (Borei) , 瑰 花 (maikaika), mao (maou), parasol mao (maizen), mao radish (maoukon), macri (marine herb, macri), machinin (mashinin), matababi vine (crane), heaven tree vine (Tenmokutsuru), Matatabi fruit, Amagi fruit (Tenmokujitsu), pine nut (Matsunomi), Haimatsuko (Kaishushiushi), Matsuba (Matsuba), Matsufuji (Matsufuji), Matsuyani, Matsuwa (shoushi), vine (Mankeishi) ), Mitsumouka, Beeswax beeswax, Milobaran, Oak, Fig fruit (no flower, Mukaka), Fig leaf, Meguri tree, Cotton chin (Mentinchin), Bandit (Mokuzoku), Tree Tsutsu (Mokutsu), Kitsuko (Mokutsuushi), Kite Tengu (Mokuten Ryo), Mata Tabi's Aneurysm (Mushi Kobu), Kiso (Mokka), Mika (Mokkou), Peach Leaves (Momonoha), Horsetail, Gate Mongkei, Yakuchi, Yakuchi, Yakuchinin, Yakumosou, Yakouto, Yashajitsu, Yatsumelan, Bear Gall (Yutan), under the snow (Yukinoshita), lily leaf, lily root (lily, sandalwood), yokuinin, thunder circle (raigan), 莱 fukuko (lifekushi), arabiko (rabushika), rahanka (Recompilation), Longan (Ryuganiku), Liu Yid (Ryukido), Ryu (Ryukotsu), Ryutan (Ryutan), Ryokyo (Ryoku), Mung Bean (Ryokuzu), Ganoderma (Ryokuzu), Renji (Lenghi) C) RenSenkusa (Rensensou), lotus meat (Ren'niku), antler (six-rowed), Rohachibo (Rohoubou), road-road communication (Rorotsuu), and the like sum 羌活 (Wakyoukatsu).
漢方薬製剤としては、特に限定されるものではないが、厚生省で使用認可を受けていた諸漢方エキス製剤が挙げられる。 The Chinese herbal medicine preparation is not particularly limited, but includes various Chinese herbal extract preparations that have been approved for use by the Ministry of Health and Welfare.
4.投与形態
本発明の組成物の投与形態は、特に限定されないが、例えば、経口投与、局所投与、ワンショット静注、点滴静注、持続点滴静注、動注、腹腔内投与、皮下投与、腔内投与などがある。4). Administration form The administration form of the composition of the present invention is not particularly limited, and for example, oral administration, topical administration, one-shot intravenous injection, intravenous infusion, continuous intravenous infusion, intraarterial injection, intraperitoneal administration, subcutaneous administration, cavity Such as internal administration.
本発明の組成物の剤型は特に限定されないが、経口剤および非経口剤であることができる。例えば、本発明において、ナンキンハゼの乾燥物、ナンキンハゼの抽出物、或いは、前期抽出物の乾燥品を含む材料を下記剤型に加工することができる。 Although the dosage form of the composition of this invention is not specifically limited, It can be an oral agent and a parenteral agent. For example, in the present invention, a material containing a dried peanut, a peanut extract, or a dried product of the previous extract can be processed into the following dosage form.
経口剤としては、例えば、カプセル剤、散剤、顆粒剤、液剤、シロップ剤、ドリンク剤などの内服剤が挙げられる。この場合、本発明の組成物とともに、結合剤、賦形剤、膨化剤、滑沢剤、甘味剤、香味剤などを用いるこことができる。ここで、錠剤は、シェラック、または砂糖で被覆することもできる。また、カプセル剤は、上記の材料にさらに油脂などの液体担体を含有させることもできる。シロップ剤およびドリンク剤には、甘味料、防腐剤、色素香味剤などを含有させてもよい。 Examples of oral preparations include internal preparations such as capsules, powders, granules, liquids, syrups, and drinks. In this case, a binder, an excipient, a swelling agent, a lubricant, a sweetener, a flavoring agent and the like can be used together with the composition of the present invention. Here, the tablets can also be coated with shellac or sugar. Moreover, the capsule can also contain liquid carriers, such as fats and oils, in said material. Syrups and drinks may contain sweeteners, preservatives, pigment flavors and the like.
非経口剤としては、例えば、軟膏剤、クリーム剤、水剤などの外用剤、注射剤、坐剤などが挙げられる。外用剤の基材としては、ワセリン、パラフィン、油脂類、ラノリン、マクロコールドなどが用いられ、通常の方法によって、軟膏剤やクリーム剤などとすることができる。注射剤としては、液剤、乾燥剤、凍結乾燥剤などが挙げられる。乾燥剤、凍結乾燥剤は、使用時に注射用蒸留水や生理食塩液などに無菌的に溶解して用いられる。 Examples of parenterals include external preparations such as ointments, creams, and liquids, injections, and suppositories. As a base material for external preparations, petrolatum, paraffin, fats and oils, lanolin, macrocold, etc. are used, and can be made into ointments, creams and the like by ordinary methods. Examples of injections include liquids, desiccants, and lyophilization agents. The desiccant and lyophilizer are used aseptically dissolved in distilled water for injection or physiological saline at the time of use.
本発明の組成物を有効成分として、食品製剤を調製することができる。この場合、前記食品製剤は、抗悪液質作用を有する。また、この場合、種々の食品素材または飲料品素材を添加することによって、例えば、粉末状、錠剤状、カプセル状、液状(ドリンク剤)などの形態の食品製剤とすることができる。また、この食品製剤には、基材、賦形剤、添加剤、副素材、増量剤などを適宜添加してもよい。前記食品製剤は、1日数回に分けて経口摂取させるのが好ましい。 A food preparation can be prepared using the composition of the present invention as an active ingredient. In this case, the food preparation has an anti-cachexia effect. Further, in this case, by adding various food materials or beverage materials, for example, a food preparation in the form of powder, tablet, capsule, liquid (drink) can be obtained. Moreover, you may add a base material, an excipient | filler, an additive, a subsidiary material, a bulking agent, etc. to this food formulation suitably. The food preparation is preferably taken orally in several divided doses per day.
また、本発明の食品製剤に、他の機能性物質(例えば、ヒメマツタケ、霊芝、カワラタケなどのキノコ類、その抽出物およびこれらの加工物)を副素材として添加することは、機序が異なった多彩な効果が発揮される点で好ましい。 In addition, the addition of other functional substances (for example, mushrooms such as Japanese matsutake, ganoderma mushrooms, and bamboo shoots, extracts thereof and processed products thereof) to the food preparation of the present invention is a different mechanism. It is preferable in that various effects are exhibited.
これらの食品製剤は、がんまたは腫瘍、糖尿病、内分泌疾患、血液系疾患、結核などの疾患における悪液質の改善、若しくは悪液質の発生を防止したいヒトまたはヒト以外の動物に対して使用される。 These food preparations are used for humans or non-human animals who want to improve cachexia or prevent the occurrence of cachexia in diseases such as cancer or tumors, diabetes, endocrine diseases, blood system diseases, tuberculosis, etc. Is done.
以下、実施例に基づき、本発明をさらに具体的に説明するが、本発明はこの実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated further more concretely based on an Example, this invention is not limited to this Example.
ナンキンハゼの有効成分の調製:ナンキンハゼは、中国平和県県立病院に依頼し、その産地である中国平和県で採取した。新鮮根皮の表皮を除去し、15グラムの柔組織部と内皮を得た。これらの柔組織部と内皮を100ミリリットルの蒸留水に浸して、低温(2〜8℃)にて24時間静置した。その浸した溶液をナンキンハゼ抽出液とした。この抽出液を患者に経口投与した。3日後、2回目の投与、さらに3日後、3回目の投与を行った。3週間後、投与前後における臨床症状の変化を比較し、評価を行った。 Preparation of active ingredient of Nankin goby: Nankin goby was collected from the Heiwa Prefectural Hospital, China, and collected from the producing area. The epidermis of fresh root bark was removed to obtain 15 grams of soft tissue part and endothelium. These soft tissue parts and endothelium were immersed in 100 ml of distilled water and allowed to stand at low temperature (2 to 8 ° C.) for 24 hours. The soaked solution was used as a peanut extract. This extract was orally administered to patients. Three days later, the second administration was performed, and further three days later, the third administration was performed. Three weeks later, changes in clinical symptoms before and after administration were compared and evaluated.
臨床における症状所見は、以下の程度に分類し、数値化して評価した。 Clinical symptom findings were classified into the following grades and evaluated numerically.
0:症状なし。I:軽度(症状はわずかあるが、気になる程はない)。II:中程度(症状はかなりあるが、我慢できる)。III:高度(症状が強く、日常生活に支障が来す)。 0: No symptoms. I: Mild (slight symptom but not so worrisome). II: Moderate (subject to symptom but patient) III: Altitude (strong symptom, disturbing daily life).
被験者に対し、本実験のプログラムと本実験に参加する場合のメリットとリスクを説明し、同意を得た上で実験を行った。 We explained the program of this experiment and the merits and risks of participating in this experiment to the subjects, and conducted the experiment after obtaining consent.
被験者C、男性、63才、食道扁平上皮癌(中部)、末期、病状進行などによる治療を断念した症例であった。臨床所見は、体重減少(II)、倦怠感(III)、無表情性顔貌(III)、食欲不振(III)、下肢浮腫(I)等の悪液質に特有な症状がみられた。 Subject C, male, age 63, abandoned treatment due to esophageal squamous cell carcinoma (middle), terminal stage, disease progression, etc. The clinical findings showed symptoms peculiar to cachexia such as weight loss (II), fatigue (III), expressionless facial appearance (III), loss of appetite (III), lower limb edema (I).
ナンキンハゼ投与後3週間目に、評価を行った。臨床所見として、倦怠感が軽減(II)、精神状態が顕著に改善(II)、食欲が回復(II)、食後の吐気も軽減した(I)。下肢の浮腫にも少々の改善(I)がみられた。体重は57.5kgから59.3kgまでに増加した(図1)。 Evaluation was performed 3 weeks after administration of peanut. Clinical findings included reduced fatigue (II), markedly improved mental status (II), appetite recovery (II), and reduced postprandial nausea (I). There was also a slight improvement (I) in lower limb edema. Body weight increased from 57.5 kg to 59.3 kg (FIG. 1).
本症例における臨床指標の改善が極めて著しいので、ナンキンハゼの悪液質改善治療における効果が認められた。 The improvement of clinical index in this case was extremely remarkable, and the effect of nankin goby on cachexia improvement treatment was recognized.
被験者L、男性、57才、胃粘液腺癌、末期。臨床所見は、痩せ(II)、倦怠感(III)、蒼白顔色(I)、食欲不振(III)、下肢浮腫(I)、日常行動が極端に少ない(III)等の悪液質に特有な症状がみられた。被験者Cと同様に、有効な治療方法がないため、治療を断念した。 Subject L, male, 57 years old, gastric mucinous adenocarcinoma, terminal stage. Clinical findings are characteristic of cachexia such as lean (II), malaise (III), pale complexion (I), anorexia (III), lower limb edema (I), and extremely low daily behavior (III) Symptoms were seen. Similar to Subject C, treatment was abandoned because there was no effective treatment method.
ナンキンハゼ投与後3週間目の臨床所見として、精神状態が顕著に改善(I)、食欲が回復(II)、食後の吐気が軽減(I)、下肢の浮腫(I)にも改善がみられた。日常行動、特に歩行が顕著に増加し(I)、見回りのことは自分で対処するようになった。体重は51.5kgから52.5kgまでに増加した(図1)。 Clinical findings 3 weeks after administration of peanuts showed significant improvement in mental status (I), recovery of appetite (II), reduced postprandial nausea (I), and improvement in lower limb edema (I) . Daily behavior, especially walking, increased significantly (I), and I was able to deal with patrols on my own. Body weight increased from 51.5 kg to 52.5 kg (FIG. 1).
本症例における臨床指標の改善が極めて著しいので、ナンキンハゼの悪液質改善治療における効果が認められた。 The improvement of clinical index in this case was extremely remarkable, and the effect of nankin goby on cachexia improvement treatment was recognized.
以上の結果から、ナンキンハゼの悪液質改善治療作用があることが明らかになった。また、ナンキンハゼの悪液質改善効果における再現性があることも判明した。 From the above results, it has been clarified that Nankin goby has a cachexia improving therapeutic action. In addition, it was also found that there is reproducibility in the cachexia improving effect of peanut.
本発明のナンキンハゼおよび/またはその抽出物は、医薬品、医薬部外品および食品製剤として用いることができる。 The peanut and / or extract thereof of the present invention can be used as pharmaceuticals, quasi drugs and food preparations.
なし。None.
Claims (2)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005244955A JP2009046391A (en) | 2005-07-06 | 2005-07-06 | Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action |
| JP2007523389A JPWO2007004390A1 (en) | 2005-07-06 | 2006-06-12 | Cachexia improving preparation and cachexia improving food |
| PCT/JP2006/311782 WO2007004390A1 (en) | 2005-07-06 | 2006-06-12 | Cachexia improving preparation and cachexia improving food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005244955A JP2009046391A (en) | 2005-07-06 | 2005-07-06 | Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2009046391A true JP2009046391A (en) | 2009-03-05 |
Family
ID=37604265
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005244955A Pending JP2009046391A (en) | 2005-07-06 | 2005-07-06 | Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action |
| JP2007523389A Pending JPWO2007004390A1 (en) | 2005-07-06 | 2006-06-12 | Cachexia improving preparation and cachexia improving food |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007523389A Pending JPWO2007004390A1 (en) | 2005-07-06 | 2006-06-12 | Cachexia improving preparation and cachexia improving food |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JP2009046391A (en) |
| WO (1) | WO2007004390A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101164515B1 (en) * | 2009-11-05 | 2012-07-11 | 한국 한의학 연구원 | Composition for Prevention or Treatment of Disease Originated from Influenza Virus |
| WO2012108744A3 (en) * | 2011-02-11 | 2012-12-27 | 주식회사 한국전통의학연구소 | Composition and health functional food for treating brain cancer comprising inula flower extract |
| US8623426B2 (en) | 2009-11-04 | 2014-01-07 | Korea Institute Of Oriental Medicine | Composition for preventing or treating diseases caused by influenza viruses |
| KR101438555B1 (en) * | 2012-09-18 | 2014-09-05 | 씨제이헬스케어 주식회사 | Composition for improving anorexia containing herb medicines extracts |
| JP2015134730A (en) * | 2014-01-17 | 2015-07-27 | ポーラ化成工業株式会社 | Oral composition |
| KR20190103987A (en) * | 2018-02-28 | 2019-09-05 | 중앙대학교 산학협력단 | Composition for Preventing, Improving or Treating Cachexia and Muscle Loss |
| KR20190129262A (en) * | 2018-05-10 | 2019-11-20 | 경희대학교 산학협력단 | Composition for treatment or prevention of cancer comprising extract of Salvia miltiorrhiza and Prunus persica Batsch |
| KR102124986B1 (en) * | 2019-04-22 | 2020-06-22 | (주)에프앤디넷 | Composition for prevention or treatment of muscular disorder or improvement of muscular functions comprising Leonurus japonicus extract or leonurine |
| WO2021187905A1 (en) * | 2020-03-20 | 2021-09-23 | ㈜송헌알앤디 | Pharmaceutical composition for cancer and resistant cancer comprising trichosanthes kirilowii maxim, dictamnus dasycarpus turcz and morus alba l. |
| WO2022098192A1 (en) * | 2020-11-09 | 2022-05-12 | 경희대학교 산학협력단 | Composition for preventing or treating cachexia comprising medicinal herb complex extract |
| WO2022225297A1 (en) * | 2021-04-21 | 2022-10-27 | 한국한의학연구원 | Composition for prevention, amelioration or treatment of cachexia |
| WO2023048504A1 (en) * | 2021-09-23 | 2023-03-30 | (주)휴온스 | Composition for preventing or treating muscle weakness-associated diseases or sarcopenia, containing rosa davurica pallas extract as active ingredient |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101031140B1 (en) * | 2008-11-03 | 2011-04-27 | 남종현 | Pharmaceutical composition for treating and preventing cancer and health functional food for improving and preventing cancer comprising the same |
| WO2012024006A2 (en) | 2010-05-21 | 2012-02-23 | Princeton University | Structures for enhancement of local electric field, light absorption, light radiation, material detection and methods for making and using of the same |
| KR101189191B1 (en) | 2010-06-24 | 2012-10-09 | 한국과학기술연구원 | Composition comprising longan arillus extract or mixed extracts comprising the same for neurodegenerative diseases |
| JP5714841B2 (en) * | 2010-06-28 | 2015-05-07 | ポッカサッポロフード&ビバレッジ株式会社 | Method for producing wolffish extract and solution of dragonfly extract |
| JP6130283B2 (en) * | 2013-10-29 | 2017-05-17 | 株式会社えんばく生活 | Food composition derived from bran bran and method for producing the same |
| KR101579763B1 (en) * | 2014-07-22 | 2015-12-23 | 한국 한의학 연구원 | Pharmaceutical compositions and health functional foods comprising Pellionia scabra extracts for preventing or treating cancers |
| CN104173394B (en) * | 2014-08-13 | 2018-01-19 | 青岛市中心医院 | A kind of pharmaceutical composition of anti-breast cancer and its production and use |
| CN104189223B (en) * | 2014-08-25 | 2016-09-07 | 烟台市华文欣欣医药科技有限公司 | A kind of pharmaceutical composition for promoting wound healing and preparation method thereof |
| CN104224989A (en) * | 2014-09-29 | 2014-12-24 | 麻江县生产力促进中心有限责任公司 | Traditional Chinese medicine for treating burn and scald |
| CN105624282B (en) * | 2015-12-04 | 2020-08-18 | 江西师范大学 | Method for development and application of endangered rhododendron molle polymorphism SSR molecular marker |
| CN109041630A (en) * | 2018-06-26 | 2018-12-21 | 贵州来福农业科技有限责任公司 | A kind of hypoglycemic Rosa roxburghii Tratt bitter buckwheat seedling oral solution and preparation method thereof |
| KR102167725B1 (en) * | 2018-09-21 | 2020-10-19 | 원광대학교 산학협력단 | Compositions for preventing or treating oral disease or bone disease comprising extracts of Asplenium incisum |
| CN110243991A (en) * | 2019-06-13 | 2019-09-17 | 广西中医药大学 | A kind of quality detection method of Yao medicine petroleum vegetable medicinal material |
| CN111202765A (en) * | 2019-11-19 | 2020-05-29 | 宁夏医科大学 | Anti-depression total flavone extract and preparation method and application thereof |
| CN110972956A (en) * | 2020-01-02 | 2020-04-10 | 昭通芸生农业科技开发有限公司 | Pleione seed tissue culture method |
| CN112155020B (en) * | 2020-10-10 | 2021-10-01 | 中国农业大学 | The use of guanoye tuerfeng in biological control and its biological control agent and preparation method |
| CN112359135B (en) * | 2020-12-14 | 2022-04-29 | 西南交通大学 | Indel-labeled primers of Fritillaria taeba and its application |
| CN113080373A (en) * | 2021-05-19 | 2021-07-09 | 贵州老锄头食品股份有限公司 | Buckwheat and carex baccans noodles and preparation method thereof |
| CN113243296B (en) * | 2021-06-24 | 2023-05-05 | 贵州省林业科学研究院 | Method for sterilizing and proliferation-inducing red stems of tiger tongue |
| CN113797240B (en) * | 2021-10-21 | 2022-07-12 | 河南省纳普生物技术有限公司 | Application of a total polyphenolic extract of white tung tree in the preparation of drugs for inhibiting calcium ion channels |
| KR102611957B1 (en) * | 2021-11-03 | 2023-12-08 | 동의대학교 산학협력단 | Composition for preventing or treating muscular disease comprising syneilesis aconitifolia (bunge) maxim extract |
| KR102611924B1 (en) * | 2021-11-03 | 2023-12-08 | 동의대학교 산학협력단 | Composition comprising syneilesis aconitifolia (bunge) maxim extract thereof for preventing and treating of periodontitis |
| KR102542119B1 (en) * | 2021-11-03 | 2023-06-13 | 동의대학교 산학협력단 | Composition for preventing or treating inflammatory airway diseases caused fine dust comprising syneilesis aconitifolia (bunge) maxim extract |
| CN114601780B (en) * | 2022-03-30 | 2023-10-24 | 中国药科大学 | Anti-inflammatory antibacterial traditional Chinese medicine compound mouthwash and preparation method thereof |
-
2005
- 2005-07-06 JP JP2005244955A patent/JP2009046391A/en active Pending
-
2006
- 2006-06-12 WO PCT/JP2006/311782 patent/WO2007004390A1/en not_active Ceased
- 2006-06-12 JP JP2007523389A patent/JPWO2007004390A1/en active Pending
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8623426B2 (en) | 2009-11-04 | 2014-01-07 | Korea Institute Of Oriental Medicine | Composition for preventing or treating diseases caused by influenza viruses |
| KR101164515B1 (en) * | 2009-11-05 | 2012-07-11 | 한국 한의학 연구원 | Composition for Prevention or Treatment of Disease Originated from Influenza Virus |
| US8591962B2 (en) | 2009-11-05 | 2013-11-26 | Korea Institute Of Oriental Medicine | Composition for preventing and treating influenza-virus-induced diseases |
| WO2012108744A3 (en) * | 2011-02-11 | 2012-12-27 | 주식회사 한국전통의학연구소 | Composition and health functional food for treating brain cancer comprising inula flower extract |
| KR101438555B1 (en) * | 2012-09-18 | 2014-09-05 | 씨제이헬스케어 주식회사 | Composition for improving anorexia containing herb medicines extracts |
| JP2015134730A (en) * | 2014-01-17 | 2015-07-27 | ポーラ化成工業株式会社 | Oral composition |
| JP2021514993A (en) * | 2018-02-28 | 2021-06-17 | チュンアン・ユニヴァーシティ・インダストリー・アカデミック・コーペレーション・ファウンデーション | Compositions for the prevention, amelioration or treatment of cachexia and muscle loss |
| WO2019168388A1 (en) * | 2018-02-28 | 2019-09-06 | 중앙대학교 산학협력단 | Composition for preventing, alleviating, or treating cachexia and muscle loss |
| KR102166949B1 (en) | 2018-02-28 | 2020-10-16 | 중앙대학교 산학협력단 | Composition for Preventing, Improving or Treating Cachexia and Muscle Loss |
| KR20190103987A (en) * | 2018-02-28 | 2019-09-05 | 중앙대학교 산학협력단 | Composition for Preventing, Improving or Treating Cachexia and Muscle Loss |
| JP7132344B2 (en) | 2018-02-28 | 2022-09-06 | チュンアン・ユニヴァーシティ・インダストリー・アカデミック・コーペレーション・ファウンデーション | Compositions for preventing, ameliorating or treating cachexia and muscle loss |
| US11684650B2 (en) | 2018-02-28 | 2023-06-27 | Chung-Ang University Industry Academic Cooperation Foundation | Composition for preventing, alleviating, or treating cachexia and muscle loss |
| KR20190129262A (en) * | 2018-05-10 | 2019-11-20 | 경희대학교 산학협력단 | Composition for treatment or prevention of cancer comprising extract of Salvia miltiorrhiza and Prunus persica Batsch |
| KR102113140B1 (en) | 2018-05-10 | 2020-05-20 | 경희대학교 산학협력단 | Composition for treatment or prevention of cancer comprising extract of Salvia miltiorrhiza and Prunus persica Batsch |
| KR102124986B1 (en) * | 2019-04-22 | 2020-06-22 | (주)에프앤디넷 | Composition for prevention or treatment of muscular disorder or improvement of muscular functions comprising Leonurus japonicus extract or leonurine |
| WO2021187905A1 (en) * | 2020-03-20 | 2021-09-23 | ㈜송헌알앤디 | Pharmaceutical composition for cancer and resistant cancer comprising trichosanthes kirilowii maxim, dictamnus dasycarpus turcz and morus alba l. |
| WO2022098192A1 (en) * | 2020-11-09 | 2022-05-12 | 경희대학교 산학협력단 | Composition for preventing or treating cachexia comprising medicinal herb complex extract |
| WO2022225297A1 (en) * | 2021-04-21 | 2022-10-27 | 한국한의학연구원 | Composition for prevention, amelioration or treatment of cachexia |
| WO2023048504A1 (en) * | 2021-09-23 | 2023-03-30 | (주)휴온스 | Composition for preventing or treating muscle weakness-associated diseases or sarcopenia, containing rosa davurica pallas extract as active ingredient |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2007004390A1 (en) | 2009-03-05 |
| WO2007004390A1 (en) | 2007-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009046391A (en) | Pharmaceutical preparation for improving and treating cachexia and food preparation having cachexia-improving action | |
| CN102573871A (en) | Chinese herbal medicine composition for diminishing inflammation, reducing swelling and relieving pain, preparation method and application thereof | |
| Kumar | Ganoderma lucidum: A traditional chinese medicine used for curing tumors | |
| CN104799048A (en) | Feed capable of improving Truogx sinensis disease resistance, and preparation method thereof | |
| CN103749822A (en) | Fructus ligustri lucidi health-care tea for lowering blood pressure and lipid and preparation method thereof | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| KR20020085401A (en) | Composition for the prophylaxis or treatment of male reproductivity depression, or for the stimulation of haematogenesis | |
| CN104522661A (en) | Healthy buccal tablets containing honeysuckle extract and production method thereof | |
| CN109223886A (en) | Chinese medicine composition and its preparation method and application for invigorating the spleen to arrest diarrhea | |
| CN104857271B (en) | Strengthen immunity of organisms prepared slices of Chinese crude drugs combination preparation, preparation method and assembly packaging | |
| CN106215118A (en) | Antineoplastic health preparation and preparation method thereof | |
| CN111407850A (en) | Plant selenium sealwort tablet and preparation method thereof | |
| CN106562074A (en) | Liquid fish-flavored cat food composition and preparation method thereof | |
| CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
| CN103110684A (en) | Soft capsule having assistant protective effect on gastric mucosa and preparation method thereof | |
| KR102376168B1 (en) | one room difference and the manufacturing method thereof the error person and Yin and Yang Kwak to the main raw material | |
| CN108057115A (en) | A kind of composition for treating inflammation of upper respiratory tract infection and preparation method thereof | |
| KR20120024186A (en) | A composition of health supplementary food and method thereof | |
| CN105878655A (en) | Herba lysimachiae eulektrol particles for treating cholelithiasis | |
| CN109528984A (en) | A kind of cream formula and preparation method by smearing breast treatment mammary gland disease | |
| CN104799007A (en) | Chinese herbal medicine additive for enhancing disease resistance of Truogx sinensis and preparation method thereof | |
| CN115006480B (en) | Traditional Chinese medicine composition for treating osteoporosis and preparation method thereof | |
| CN109646665A (en) | Cortex Eucommiae clearing lung-heat anticancer solid tea and preparation method thereof | |
| CN106038904A (en) | Herba lysimachiae and eulektrol particle composite and preparation method | |
| CN109568496B (en) | A kind of detection method of traditional Chinese medicine composition for treating diabetes |